Related Experiment Videos

[Pathophysiologic aspects of hyperlipoproteinemias]

V Soska1

  • 1Oddĕlení klinické biochemie FN U sv. Anny, Brno.

Vnitrni Lekarstvi
|May 10, 2001
PubMed

Insights

High LDL-cholesterol and low HDL-cholesterol are key risks for ischemic heart disease (IHD). Other lipid factors like IDL, VLDL, and lipoprotein(a) also increase IHD risk, alongside non-lipid factors.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Atherosclerosis Research

Context:

  • Ischemic heart disease (IHD) is a leading cause of mortality.
  • Understanding the multifaceted lipid profiles contributing to IHD is crucial for effective prevention and treatment strategies.
  • Current research highlights the complex interplay of various lipoprotein particles and their role in cardiovascular risk.

Purpose:

  • To elucidate the independent contributions of specific lipoprotein subfractions and lipid parameters to the risk of developing ischemic heart disease.
  • To emphasize the importance of considering a comprehensive lipid profile, including triglycerides-rich lipoproteins and lipoprotein(a), in cardiovascular risk assessment.
  • To highlight the necessity of integrating non-lipid risk factors with lipid levels for a holistic patient evaluation.

Summary:

  • Elevated low-density lipoprotein (LDL) cholesterol and reduced high-density lipoprotein (HDL) cholesterol are established independent risk factors for IHD.
  • Atherogenesis is further promoted by triacylglycerol-rich lipoproteins, including intermediate-density lipoproteins (IDL) and very-low-density lipoproteins (VLDL).
  • Increased concentrations of LDL subfractions (LDLIII), protracted postprandial lipemia (chylomicron remnants), and lipoprotein(a) independently elevate IHD risk.

Impact:

  • Provides a detailed overview of lipid-related risk factors for ischemic heart disease.
  • Informs clinical practice by underscoring the need for comprehensive cardiovascular risk assessment beyond basic lipid panels.
  • Contributes to the ongoing research into the pathophysiology of atherosclerosis and the development of targeted therapies.

Related Concept Videos